MICROBIOLOGICAL CHARACTERISTICS OF COMMUNITY-ACCURED PNEUMONIA IN PATIENTS WITH TYPE 2 DIABETES TREATED AT THAI NGUYEN NATIONAL HOSPITAL

Thị Hương Nhài Nông, Kim Liên Phạm, Thanh Nga Quản

Main Article Content

Abstract

Objective: To describe the microbiological characteristics of community - acquired pneumonia (CAP) in patients with type 2 diabetes mellitus treated at Thai Nguyen National Hospital. Subjects and Methods: A cross-sectional descriptive study was conducted on 117 inpatients with CAP and a history of type 2 diabetes mellitus, admitted from July 2024 to July 2025 at Thai Nguyen National Hospital. Results: Positive bacterial cultures were obtained in 35.9% of cases. Among the 42 culture-positive cases, Gram-negative bacteria accounted for 90.48%, while Gram-positive bacteria represented 4.76%. Specifically, Klebsiella pneumoniae was isolated in 40.9% of cases, Acinetobacter baumannii in 21.4%, and Pseudomonas aeruginosa in 4.5%. Gram-positive bacteria included Streptococcus pneumoniae and Staphylococcus aureus (1.5%). Fungal isolates of Candida albicans were detected in 4.5%. Negative cultures were more frequent in patients with well-controlled diabetes, whereas positive cultures predominated in poorly controlled diabetes. The difference was statistically significant (p < 0.05). Conclusion: The findings demonstrate a clear predominance of Gram-negative bacteria, particularly Klebsiella pneumoniae and Acinetobacter baumannii. Higher rates of positive cultures were observed in patients with poor glycemic control, underscoring the importance of blood glucose management in reducing infection risk. Empirical antibiotic selection should prioritize coverage against Gram-negative pathogens, with close monitoring of antibiotic susceptibility testing and strict glycemic control. Enhanced screening, preventive measures, and risk factor management are essential to improve patient outcomes.

Article Details

References

1. W. H. Organization, "Pneumonia," 2023, Available: https://www.who.int/news-room/fact-sheets/detail/pneumonia.
2. P. Saeedi et al., "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition," (in eng), Diabetes Res Clin Pract, vol. 157, p. 107843, Nov 2019.
3. J. A. Critchley, I. M. Carey, T. Harris, S. DeWilde, F. J. Hosking, and D. G. Cook, "Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study," (in eng), Diabetes care, vol. 41, no. 10, pp. 2127-2135, 2018.
4. S. Di Yacovo et al., "Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus," vol. 92, no. 1, pp. 42-50, 2013.
5. M. La, "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults," (in eng), Clin Infect Dis., vol. 44, pp. S27-S72, 2019.
6. P. K. Liên, Giáo trình bệnh học hô hấp (Viêm phổi mắc phải cộng đồng). Hà Nội: Nhà xuất bản Y học, 2025.
7. R. K. Bhattacharya, J. D. Mahnken, and S. K. Rigler, "Impact of admission blood glucose level on outcomes in community-acquired pneumonia in older adults," (in eng), Int J Gen Med, vol. 6, pp. 341-4, 2013.
8. J. Almirall et al., "New evidence of risk factors for community-acquired pneumonia: a population-based study," (in eng), European respiratory journal, vol. 31, no. 6, pp. 1274-1284, 2018.